-
121
TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population
Published 2013-01-01“…TSP-1 is a glycoprotein that functions in the biology of bladder cancer. We investigated the relationship between the distribution of TSP-1-1223 A/G polymorphism (rs2169830) and the clinical characteristics of bladder cancer. …”
Get full text
Article -
122
Mycobacterial Brain Tuberculomas due to Bacille Calmette-Guérin Intravesical Chemotherapy for Bladder Cancer: A Case Report and Literature Review
Published 2011-01-01“…Bacille Calmette-Guérin (BCG) immunotherapy is widely used for the treatment of superficial bladder cancer. The authors believe that the present report is one of the first to document cerebral BCG tuberculoma in a 73-year-old immunocompetent man, three years after intra-vesical BCG immunotherapy. …”
Get full text
Article -
123
Hypoxia-Induced Autophagy Enhances Cisplatin Resistance in Human Bladder Cancer Cells by Targeting Hypoxia-Inducible Factor-1α
Published 2021-01-01“…To investigate the effect of hypoxia on chemoresistance and the underlying mechanism in bladder cancer cells. Methods. BIU-87 bladder cancer cell line was treated with cisplatin under hypoxic and normoxic conditions and tested using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, flow cytometry, and Western blotting. …”
Get full text
Article -
124
YWHAG promotes bladder cancer metastasis by regulating TMOD3 to activate ERK1/2 and JNK phosphorylation in the MAPK pathway
Published 2024-12-01Subjects: “…Bladder cancer…”
Get full text
Article -
125
Pathological Characteristics of Primary Bladder Carcinoma Treated at a Tertiary Care Hospital and Changing Demographics of Bladder Cancer in Sri Lanka
Published 2016-01-01“…Data of newly diagnosed patients with bladder cancer in a tertiary referral centre from 2011 to 2014 were analysed. …”
Get full text
Article -
126
-
127
Use of quasi-normal form to examine stability of tumor-free equilibrium in a mathematical model of bcg treatment of bladder cancer
Published 2011-03-01“…In this work, we analyze stability in a mathematical model for BCG treatment of bladder cancer based on the use of quasi-normal form and stability theory. …”
Get full text
Article -
128
-
129
Sex-specific differences in recurrence and progression following cytostatic intravesical chemotherapy for non-muscle invasive urothelial bladder cancer (NMIBC)
Published 2025-02-01Subjects: “…Bladder cancer…”
Get full text
Article -
130
Risk factors for lymphatic leakage following radical cystectomy and pelvic lymph node dissection in patients with muscle-invasive bladder cancer
Published 2025-01-01Subjects: Get full text
Article -
131
Non-thermal plasma as promising anti-cancer therapy against bladder cancer by inducing DNA damage and cell cycle arrest
Published 2025-01-01Subjects: Get full text
Article -
132
-
133
The potential synergistic effect of combining doxorubicin with vorinostat in urothelial carcinoma therapy
Published 2025-01-01Subjects: Get full text
Article -
134
The Clinical Impact of Tumor Grade Heterogeneity in Nonmuscle- invasive Urothelial Carcinoma of the Bladder
Published 2021-12-01Subjects: “…bladder cancer…”
Get full text
Article -
135
Prospective Analysis of Confocal Laser Endomicroscopy for Assessment of the Resection Bed for Bladder Tumor
Published 2025-01-01Subjects: “…Bladder cancer…”
Get full text
Article -
136
-
137
Case report: Successful treatment of hyperbaric oxygen for radiation-induced hemorrhagic cystitis in a 95-year-old patient with bladder cancer
Published 2025-02-01Subjects: Get full text
Article -
138
Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway
Published 2025-02-01Subjects: “…Bladder cancer…”
Get full text
Article -
139
-
140
Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
Published 2013-01-01“…Data was retrospectively collected on 178 patients with T2-T4 bladder cancer who underwent radical cystectomy between 2003 and 2011. …”
Get full text
Article